Riskpilot← Back to searchSign inGet full accessSalofa Oy
OYActiveY-tunnus 2564847-9Satamakatu 16Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201314 employees
Revenue 2024
EUR 1,1M
-17% vs 2023
EBITDA margin
-126.3%
+4% vs 2023
Equity ratio
60.1%
Financial strength
Net profit 2024
EUR -1,6M
+6% vs 2023
| Revenue | EUR 1,1M | -17% |
| EBITDA | EUR -1,4M | +4% |
| Net profit | EUR -1,6M | +6% |
| Total assets | EUR 4,5M | -8% |
| Equity | EUR 2,7M | -38% |
| Employees | 14 | — |
Legal name
Salofa Oy
Y-tunnus number
2564847-9
Legal form
Osakeyhtiö
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20. elokuuta 2013
Share capital
EUR 864 500
Employees
14 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja yksin
Company purpose
Yhtiön toimialana on kemiallisten testien ja niihin liittyvien pakkausten valmistus, sairaalalaitteiden sekä terveydenhuollon tarvikkeiden valmistus, markkinointi, myynti ja konsultointi sekä kotimaassa että ulkomailla, jonka lisäksi yhtiö voi omistaa, ostaa ja myydä osakkeita ja kiinteää omaisuutta.
Address
Satamakatu 16
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 277 | 13 091 | 16 710 | 1 366 | 1 140 |
| Staff expenses | −582 | −644 | −685 | −627 | −704 |
| EBITDA | 942 | 4 672 | 4 970 | −1 493 | −1 440 |
| Depreciation & amort. | −457 | −314 | −1 154 | −239 | −154 |
| EBIT | 485 | 4 358 | 3 816 | −1 732 | −1 594 |
| Net financials | −103 | −98 | 421 | −9 | −49 |
| Profit before tax | 382 | 4 260 | 4 237 | −1 741 | −1 643 |
| Tax | −0 | 853 | 848 | −0 | −0 |
| Net profit | 382 | 3 407 | 3 389 | −1 741 | −1 643 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 226 | 5 887 | 7 156 | 4 841 | 4 463 |
| Equity | 1 017 | 3 768 | 6 095 | 4 339 | 2 680 |
| Long-term debt | 577 | 126 | — | 0 | 401 |
| Short-term debt | 633 | 1 992 | 1 061 | 503 | 1 381 |
| Total debt | 1 210 | 2 119 | 1 061 | 503 | 1 782 |
EBITDA margin
-126.3%
This company
15.8%
Market median
-899% vs market
20202024
Equity ratio
60.1%
This company
38.2%
Market median
+57% vs market
20202024
Return on equity
-61.3%
This company
18.4%
Market median
-433% vs market
20202024
Net profit margin
-144.2%
This company
8.1%
Market median
-1880% vs market
20202024
Asset turnover
0.26×
This company
1.12×
Market median
-77% vs market
20202024
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
TV | Audit | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2014 | |
| Board of Directors | 2024 | |
| Chairperson | 2014 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Former (1) | ||
| Board of Directors | 2014 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Salofa Oy 
Anidiagnostics OyBoard members of Salofa Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Teemu Vihtori Suoniemi | Audit | 0 companies |
| Ragnar Christoffer Riska | Board of Directors | 0 companies |
| John Raymond Ekholm | Board of Directors | 0 companies |
| Thommy Jan Michael Hellberg | Chairperson | 0 companies |
| Mika Petteri Saramäki | Board of Directors | 0 companies |
| Jan Marcus Hellberg | Board of Directors | 0 companies |
| Björn Eric Christer Gillberg | Board of Directors | 0 companies |